Deminor is funding a group of institutional investors that suffered substantial losses on their investments in common shares of Royal Dutch Philips N.V. These investors hold Philips and various (former) Philips D&O’s liable for the late disclosure of a serious quality issue relating to PE-PUR foam degradation in CPAP, BiPAP and mechanical ventilator devices produced, sold and marketed by Philips.
While within the Philips group as from 2015 concrete knowledge existed about this quality issue and the potential risk for patients and users of these devices, Philips only (partially) disclosed this issue in April 2021 to the markets and regulators.
In November 2024 litigation was commenced on behalf of Deminor’s clients before the court of Amsterdam.
Company names
Royal Dutch Philips N.V./Koninklijke Philips N.V
The Netherlands
Contact person
✉️ Joeri Klein
